Summary of Significant Accounting Policies - Significant components of deferred tax assets and liabilities (Details) - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Significant components of the Company's deferred tax assets and liabilities | ||
| Net operating loss carryforward | $ 23,492,415 | $ 21,035,389 |
| Stock-based compensation | 1,838,861 | 860,376 |
| Derivative liability | (475,918) | |
| Capitalized research costs | 1,487,718 | |
| Net deferred income tax assets | 26,343,075 | 21,895,765 |
| Less: Valuation Allowance | $ (26,343,075) | $ (21,895,765) |
| X | ||||||||||
- Definition Amount, after allocation deferred tax liability but before valuation allowance, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from derivatives. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|